Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Mansego, Maria Luisa ^a,e   Martínez, Fernando ^a,f   Martínez Larrad, Maria Teresa ^b,e   Zabena, Carina ^b,e   Rojo, Gemma ^c,e   Morcillo, Sonsoles ^c,e   Soriguer, Federico ^c,e   Martín Escudero, Juan Carlos ^d   Serrano Ríos, Manuel ^b,e   Redon, Josep ^a,f   Chaves, Felipe Javier ^a,e  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d UNIVERSITY OF VALLADOLID   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT INTAKE; FATTY ACID BINDING PROTEIN 1 GENE; FATTY ACID BINDING PROTEIN 2 GENE; FATTY ACID BINDING PROTEIN 3 GENE; FATTY ACID BINDING PROTEIN 4 GENE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HISPANIC; HOMEOSTASIS ASSESSMENT INDEX; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ALLELE; CARDIOVASCULAR DISEASE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED; MUTATION; REGRESSION ANALYSIS; RISK FACTOR; SPAIN;

FABP1 PROTEIN, HUMAN; FABP2 PROTEIN, HUMAN; FABP3 PROTEIN, HUMAN; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN;

ADULT; AGED; ALLELES; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FATTY ACID-BINDING PROTEINS; FEMALE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RISK FACTORS; SPAIN;

EID: 84857770231     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031853     Document Type: Article

References (26)

1. Zimmerman AW, Veerkamp JH, (2002) New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci 59: 1096-1116.
2. Lara-Castro C, Hunter GR, Lovejoy JC, Gower BA, Fernandez JR, (2005) Association of the intestinal fatty acid-binding protein Ala54Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women. J Clin Endocrinol Metab 90: 1196-1201.
3. Takakura Y, Yoshioka K, Umekawa T, Kogure A, Toda H, et al. (2005) Thr54 allele of the FABP2 gene affects resting metabolic rate and visceral obesity. Diabetes Res Clin Pract 67: 36-42.
4. Vimaleswaran KS, Radha V, Mohan V, (2006) Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Metabolism 55: 1222-1226.
5. Morcillo S, Rojo-Martinez G, Cardona F, Almaraz Mde L, de Adana Mde L, et al. (2007) Effect of the interaction between the fatty acid binding protein 2 gene Ala54Thr polymorphism and dietary fatty acids on peripheral insulin sensitivity: a cross-sectional study. Am J Clin Nutr 86: 1232-1237.
6. Brouillette C, Bosse Y, Perusse L, Gaudet D, Vohl MC, (2004) Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J Hum Genet 49: 424-432.
7. Robitaille J, Brouillette C, Lemieux S, Perusse L, Gaudet D, et al. (2004) Plasma concentrations of apolipoprotein B are modulated by a gene-diet interaction effect between the LFABP T94A polymorphism and dietary fat intake in French-Canadian men. Mol Genet Metab 82: 296-303.
8. Damcott CM, Moffett SP, Feingold E, Barmada MM, Marshall JA, et al. (2004) Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males. Metabolism 53: 303-309.
9. Shin HD, Kim LH, Park BL, Jung HS, Cho YM, et al. (2003) Polymorphisms in fatty acid-binding protein-3 (FABP3)- putative association with type 2 diabetes mellitus. Hum Mutat 22: 180.
10. Ordovas JM, (2007) Identification of a functional polymorphism at the adipose fatty acid binding protein gene (FABP4) and demonstration of its association with cardiovascular disease: a path to follow. Nutr Rev 65: 130-134.
11. Mena Martin FJ, Martin Escudero JC, Simal Blanco F, Carretero Ares JL, Herreros Fernandez V, (2003) [Cardiovascular risk factors in diabetic patients. Cross-sectional study in general population: Hortega study]. An Med Interna 20: 292-296.
12. Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F, Carretero-Ares JL, Arzua-Mouronte D, et al. (2003) Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens 21: 1283-1289.
13. Mansego ML, Redon J, Marin R, Gonzalez-Albert V, Martin-Escudero JC, et al. (2008) Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens 26: 230-237.
14. Martinez-Larrad MT, Fernandez-Perez C, Gonzalez-Sanchez JL, Lopez A, Fernandez-Alvarez J, et al. (2005) [Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia]. Med Clin (Barc) 125: 481-486.
15. Galan JJ, Buch B, Pedrinaci S, Jimenez-Gamiz P, Gonzalez A, et al. (2008) Identification of a 2244 base pair interstitial deletion within the human ESR1 gene in the Spanish population. J Med Genet 45: 420-424.
16. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438.
17. Gavin JR, Alberti KG, Davidson MB, DeFronzo RA, Drash A, et al. (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (Suppl 1): S5-20.
18. Excoffier L, Slatkin M, (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12: 921-927.
19. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
20. Gauderman WJ, (2002) Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 21: 35-50.
21. Gauderman WJ, (2002) Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155: 478-484.
22. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, et al. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379.
23. Charlton M, Viker K, Krishnan A, Sanderson S, Veldt B, et al. (2009) Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology 49: 1375-1384.
24. Thompson J, Winter N, Terwey D, Bratt J, Banaszak L, (1997) The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates. J Biol Chem 272: 7140-7150.
25. Mercado MM, McLenithan JC, Silver KD, Shuldiner AR, (2002) Genetics of insulin resistance. Curr Diab Rep 2: 83-95.
26. Tobler AR, Short S, Andersen MR, Paner TM, Briggs JC, et al. (2005) The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. Journal of biomolecular techniques: JBT 16: 398-406.